News &

Press

venBio news

“venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies.”

“venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences.”

“venBio Closes $394 Million Life Sciences Venture Capital Fund.”

Portfolio news

Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio

Dec 26, 2023

ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results

Oct 3, 2023

RayzeBio Announces Closing of Upsized $358 Million IPO

Sep 19, 2023

Introducing Fierce Biotech’s 2023 Fierce 15 – FOG and RayzeBio

Aug 28, 2023

Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis

Aug 16, 2023

ImmPACT Bio Announces FDA Clearance of IND Application

Aug 15, 2023

Attovia Therapeutics Launches with $60 Million Series A Financing to Unlock Potential of Novel Biparatopic Nanobody Platform

Jun 20, 2023

San Francisco office

1700 Owens Street, Suite 595
San Francisco, CA 94158

Seattle office

1200 Westlake Ave N, Suite 900
Seattle, WA 98109

© 2024 venBio. All Rights Reserved.